Deadline for applications: 12 July 2024

TAG calls on Danaher to lower the price of GeneXpert tests for TB and other diseases to $5 each and to commit to public transparency of the cost audit of Xpert MTB/RIF Ultra.
SIGN the Time for $5 Campaign petition!

Developing new TB vaccines by 2030 is within reach if decision-makers prioritize TB vaccine R&D as a signature piece of global health and AMR agendas.

National TB programs in 13 countries worked with WHO/Europe from 2020 to 2023 to examine treatment outcomes for people on 9-month treatment regimens for MDR-TB.

Officials from several Ministries of Health have written to Danaher requesting that the price of the tests for XDR-TB, HIV and hepatitis — currently priced at $14.90 per test cartridge — also be lowered to no more than $7.97. 

TB activists call for the disease to be made a political priority in the country and demand multisectoral departmental accountability.

Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe.

WHO publishes the report of the second meeting of PADO-TB2 group providing an updated list of priorities for paediatric formulations of TB medicines.

Mike Frick, TAG TB Project Co-Director, delivered comments as a civil society representative at the WHO Director-General’s TB Vaccine Accelerator Council meeting in Geneva, Switzerland. 

First-ever International leadership summit of medical associations on achieving UN High-Level Meeting targets to end TB concludes with the Kochi Declaration.